Catalyst Wire Dossier Catalyst Wire Dossier

GIP (Glucose-dependent Insulinotropic Peptide)

glucose-dependent insulinotropic peptide
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GIP (Glucose-dependent Insulinotropic Peptide), covering 2013-11-28 to 2013-11-28. Get the full timeline:

Most recent: Clinical Trial Update: GIP: Glucose-dependent Insulinotropic Peptide [Phase 1]

See pricing